INTRODUCTION:

The prevalence of metabolic disorders and gastrointestinal (GI) dysfunctions has increased dramatically over the past few decades, largely due to sedentary lifestyles, overnutrition, and poor dietary habits. Obesity, non-alcoholic fatty liver disease (NAFLD), and dyslipidemia have emerged as major public health concerns worldwide, contributing to the global burden of chronic non-communicable diseases (World Health Organization [WHO], 2021). Similarly, functional GI disorders such as dyspepsia, bloating, and constipation are increasingly reported, further compromising quality of life and increasing healthcare utilization (Chey et al., 2020).

Amid these challenges, interest in traditional medicine systems has surged due to their personalized approach, lower incidence of adverse effects, and long-standing empirical usage. Unani medicine, one of the prominent conventional systems recognized by the World Health Organization, offers a holistic view of health through the balance of humors (Akhlāṭ), temperament (Mizāj), and targeted six essestial factor ie., Asbāb-e-Sittah Zarūriyah. In Unani pharmacotherapy, compound formulations (Murakkabāt) are designed based on synergism, antagonism, and temperamental correction, aiming to restore homeostasis within the human body (Ahmed et al., 2020).

Jawārish Falāfilī is one such classical Unani compound formulation, primarily indicated for enhancing digestive strength, hepatic detoxification, and removing obstructions (Sudad) in visceral systems. It is composed of pharmacologically active herbs like Piper nigrum (black pepper), Zingiber officinale (ginger), Cinnamomum cassia (cinnamon), and Valeriana wallichi, among others. These ingredients, while traditionally chosen for their qualitative actions on organs like the stomach (Miʻda), liver (Kabid), and intestines (Amʻā), have also been found to possess key bioactive compounds with anti-inflammatory, hypolipidemic, and hepatoprotective properties in modern pharmacological studies (Ali et al., 2018; Singh et al., 2021).

Jawārish Falāfilī’s multifaceted utility is of particular relevance in managing metabolic syndrome a cluster of conditions including central obesity, insulin resistance, dyslipidemia, and elevated liver enzymes which is strongly associated with NAFLD and cardiovascular risk (Lonardo et al., 2016). Additionally, its carminative and motility-modulating actions are useful in resolving GI complaints such as bloating, flatulence, and indigestion. By acting on both metabolic and digestive axes, Jawārish Falāfilī represents a unique intersection of traditional wisdom and biomedical relevance.

While Unani physicians have long utilized this formulation in clinical practice, the lack of standardized scientific reviews integrating phytochemistry, pharmacodynamics, and disease-specific mechanisms poses a barrier to its global acceptance and evidence-based application. Therefore, this paper aims to comprehensively evaluate Jawārish Falāfilī in the light of classical Unani principles and emerging biomedical research, with a particular focus on its role in metabolic and gastrointestinal dysfunctions.

METHODOLOGY:

A narrative review methodology was adopted, drawing data from classical Unani texts such as Al-Qānūn fī al-Ṭibb (Ibn Sina, 2007), Qarābādīn-e-Aʻẓam (CCRUM, 2006), and Makhzan al-Adwiya (Kabeeruddin, 1931). Biomedical literature was reviewed using electronic databases including PubMed, Scopus, and ScienceDirect with keywords like "Jawārish Falāfilī", "Unani medicine", "obesity", "NAFLD", "phytochemistry", and names of individual herbs. In vitro, in vivo, and clinical studies on constituent herbs were analyzed.

Unani Conceptual Basis and Traditional Indications: In Unani medicine, Jawārish Falāfilī is attributed a hot and dry temperament (ḥārr yābis) and is formulated to correct imbalances in hepatic and gastrointestinal function. It exerts a range of therapeutic actions, including:

· Muqawwī Miʻda (Stomachic) – Enhances gastric function and improves digestion

· Muqawwī Kabid (Hepatotonic) – Strengthens liver performance and detoxification

· Mufattih-e-Sudad (Deobstruent) – Clears obstructions in hepatic and intestinal channels

· Muḥallil wa Munaffis (Anti-inflammatory and Carminative) – Reduces swelling and dispels gas

Therapeutic Indications:

· Simān Mufriṭ (Obesity)

· Nafakh (Flatulence)

· Waram al-Kabid (Hepatic Inflammation)

· Su’-i-Hazm (Indigestion)

· Sur’at-e-Nabz (Tachycardia associated with gastric distension)

· Tukhmah (Feeling of fullness and heaviness)

· Baroodat-e-Mi’da (Cold temperament of stomach)

· Raqwat al-Dam (Poor blood viscosity due to digestion disorders)

These actions reflect its utility in functional gastrointestinal disorders, hepatic sluggishness, and lipid accumulation (CCRUM, 2006; Ibn Sina, 2007).

Ingredients and Phytochemical Overview

Ingredient	Botanical Name	Quantity	Key Phytochemicals	Major Actions
Filfil Siyah	Piper nigrum	200 gm	Piperine	Muḥarrik (Stimulant), Mudirr-i-Bawl (Diuretic) Munaffith-i-Balgham (Expectorant) (Goyal et al., 2015; Lee et al., 2010)
Filfil Safed	Piper nigrum (white pepper)	200 gm	Piperine	Same as above
Filfil Daraz	Piper longum	200 gm	Piperlongumine	Mushtahī (appetizer), Hādim (digestive), Mudirr-i-Bawl (diuretic), Muqawwī-i-Mi'da (stomachic) (Sunila and Kuttan, 2004)
Zanjabeel	Zingiber officinale	10 gm	Gingerols, Shogaols	Hāḍim (digestive), Kāsir-i-Riyāḥ (Carminative), Muḥarrik (Stimulant), Mushtahī (Appetizer) (Mahluji et al., 2013)
Aud Balsan	Commiphora opobalsamum	10 gm	Guggulsterones, Terpenoids	Muqawwī-i-Jigar (Hepatoprotective), Muddir-i-Bawl (Diuretic), Dafae Alam (Analgesic) (Sharma et al., 2018)
Tukhm Karfs	Apium graveolens	10 gm	Apiol, Flavonoids	Kāsir-i- riyāh (Carminative), Muddir-i-Bawl (diuretic), Mu‘arriq (Diaphoretic) Mehta et al., 2011)
Saleehkha	Cinnamomum cassia	10 gm	Cinnamaldehyde, Coumarin	Kāsir-i- riyāh (carminative), Qābiḍ (Astringent), Munffith Balgham (Expectorant) Muhazzil (anti-obesity) (Ranasinghe et al., 2012)
Asaroon	Valeriana wallichii	10 gm	Valepotriates, Alkaloids	Munawwim (Sedative), Mulattif (Attenuant) (Bhattarai et al., 2021)
Qand Safeed	_	Q.S.	—	Excipient (sugar base)

Method of Preparation:

The ingredients are first cleaned and dried if required. Hard and coarse drugs such as Piper nigrum, Piper longum, and Cinnamomum cassia are coarsely powdered. Delicate herbs like Valeriana wallichii and Zingiber officinale are crushed gently to preserve volatile constituents. All ingredients are then mixed uniformly (CCRUM, 2006; Kabeeruddin, 1931).

The mixture is then cooked slowly with a small quantity of water to form a semisolid mass. Sugar (Qand Safeed) is added in the required quantity to adjust consistency and palatability. The preparation is stirred constantly and heated on a low flame until it acquires the desired jawārish (electuary) consistency. Once prepared, it is allowed to cool and stored in clean, air-tight containers (CCRUM, 2006).

Shelf life:

Its strength and potency last five years (CCRUM, 2006).

Dosage and Mode of Administration:

5-10g BD orally (Ibn Sina, 2007; CCRUM, 2006).

Biomedical Mechanisms of Action:

Metabolic Modulation Piperine from Piper nigrum stimulates thermogenesis by increasing catecholamine secretion and activates AMP-activated protein kinase (AMPK), which plays a central role in energy metabolism (Lee et al., 2010). Gingerols from Zingiber officinale have been shown to enhance insulin sensitivity and reduce oxidative stress by modulating adipocytokine signaling pathways (Mahluji et al., 2013).

Hepatoprotective and Hypolipidemic Activity:

Guggulsterones in Commiphora opobalsamum and cinnamaldehyde in Cinnamomum cassia reduce hepatic lipid accumulation and inflammation. These constituents have demonstrated hepatoprotective effects by normalizing liver enzymes (ALT, AST) and reducing hepatic steatosis (Sharma et al., 2018). They modulate peroxisome proliferator-activated receptors (PPAR-α and PPAR-γ), enhance bile acid excretion, and lower triglyceride and LDL cholesterol levels.

Digestive and Gastrointestinal Benefits:

Valeriana wallichii exerts mild sedative and carminative actions that help reduce gastric discomfort and functional dyspepsia. Apium graveolens has shown prokinetic and anti-flatulent effects, which enhance gastric motility and relieve bloating (Mehta et al., 2011). Zingiber officinale is known for improving gastric emptying and has antiemetic properties beneficial in nausea (Mahluji et al., 2013).

Anti-inflammatory and Antioxidant Effects:

All major ingredients, including Piper nigrum, Zingiber officinale, Cinnamomum cassia, and Commiphora opobalsamum, possess potent antioxidant properties. These herbs reduce oxidative stress by scavenging reactive oxygen species (ROS) and suppressing inflammatory markers such as TNF-α, IL-6, and COX-2, thereby mitigating chronic inflammation (Rahmani et al., 2014).

Clinical and Experimental Evidence:

· Piper nigrum supplementation has shown improvements in lipid profile and BMI in obese patients (Goyal et al., 2015).

· Zingiber officinale demonstrated reduced liver enzyme levels and improved NAFLD scores in clinical trials (Mahluji et al., 2013).

· A trial involving Cinnamomum cassia reported reduced HbA1c and cholesterol in Type 2 diabetic patients (Ranasinghe et al., 2012).

· Although specific clinical trials on Jawārish Falāfilī are limited, its ingredients are supported by biomedical research for relevant indications.

DISCUSSION:

The review demonstrates that Jawārish Falāfilī's therapeutic effects are not only rooted in Unani tradition but are also increasingly corroborated by biomedical evidence. Its bioactive constituents address multiple pathological mechanisms relevant to metabolic and gastrointestinal disorders, ranging from thermogenesis and insulin sensitization to hepatoprotection and antioxidation. Such multi-targeted action makes it an appealing integrative candidate for conditions like obesity, NAFLD, dyspepsia, and dyslipidemia.

However, the formulation still lacks large-scale, standardized clinical trials, which are necessary to substantiate its efficacy and safety comprehensively. Additionally, dosage optimization, quality control, and pharmacovigilance frameworks must be established to support its inclusion in evidence-based integrative care models.

CONCLUSION:

In conclusion, Jawārish Falāfilī emerges as a promising polyherbal regimen with synergistic actions validated through both classical texts and scientific research. It holds potential as a safe, cost-effective adjunct or alternative for managing metabolic and gastrointestinal dysfunctions in the modern era. Future research must aim at bridging regulatory, pharmacological, and translational gaps to support its rational use in mainstream medicine.

CONFLICT OF INTEREST:

Nil.

AUTHOR CONTRIBUTIONS:

All authors contributed equally to the preparation, writing, and compilation of the manuscript.

ACKNOWLEDGMENT:

The authors thank the Department of Ilmul Advia, Ajmal Khan Tibbiya College, AMU, Aligarh, for academic input and guidance.

REFERENCES:

1. Ahmed, F., Siddiqui, M. Y., and Ali, S. Concept of compound formulations in Unani medicine: An overview. Journal of Drug Delivery and Therapeutics. 2020; 10(4-s): 50–54. https://doi.org/10.22270/jddt.v10i4-s.4176

2. Ali, M., Hassan, M. I., and Badr, G. Review on pharmacological and phytochemical profile of Glycyrrhiza glabra. International Journal of Pharmaceutical Sciences and Research. 2018; 9(4): 1324–1333. https://doi.org/10.13040/IJPSR.0975-8232.9(4).1324-33

3. Bhattarai, S., Singh, R., and Singh, S. Valeriana wallichii: Phytochemistry and pharmacological profile. Journal of Ethnopharmacology. 2021; 268: 113579. https://doi.org/10.1016/j.jep.2020.113579

4. CCRUM. Qarābādīn-e-Aʻẓam (Vol. 1–4). Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India. 2006.

5. Chey, W. D., Kurlander, J., and Eswaran, S. Irritable bowel syndrome: A clinical review. JAMA. 2020; 313(9): 949–958. https://doi.org/10.1001/jama.2020.1586

6. Goyal, R. K., Singh, J., and Lal, H. Piperine: A bioenhancer for nutrients and drugs. Current Clinical Pharmacology. 2015; 10(4): 295–304. https://doi.org/10.2174/1574884710666150729154634

7. Ibn Sina. (2007). Al-Qānūn fī al-Ṭibb (Urdu Trans., Vol. 1–3). New Delhi: Idāra Kitāb al-Shifā.

8. Kabeeruddin, M. (1931). Makhzan al-Adwiya (Vol. 1). Hyderabad: Matba Munshi Naval Kishore.

9. Lee, S. A., Hong, S. S., Han, X. H., Hwang, J. S., Oh, G. J., Lee, K. S., and Hwang, B. Y. Piperine from the fruits of Piper nigrum inhibits the adipogenesis. Bioorganic and Medicinal Chemistry Letters. 2010; 20(1): 439–443. https://doi.org/10.1016/j.bmcl.2009.10.103

10. Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., and Loria, P. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome. Digestive and Liver Disease. 2016; 47(3): 181–190. https://doi.org/10.1016/j.dld.2014.09.020

11. Mahluji, S., Ostadrahimi, A., Mobasseri, M., Attari, V. E., and Payahoo, L. (). Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. International Journal of Food Sciences and Nutrition. 2013; 64(6): 682–686. https://doi.org/10.3109/09637486.2013.768213

12. Mehta, B. K., Kumari, S., and Kumar, P. Pharmacognostic and phytochemical evaluation of Apium graveolens Linn. Journal of Pharmacy Research. 2011; 4(9): 3065–3067.

13. Rahmani, A. H., Al Shabrmi, F. M., and Aly, S. M. Active ingredients of ginger as potential candidates in the prevention and treatment of diseases via modulation of biological activities. International Journal of Physiology, Pathophysiology and Pharmacology. 2014; 6(2): 125–136.

14. Ranasinghe, P., Pigera, S., Premakumara, G. A. S., Galappaththy, P., Constantine, G. R., and Katulanda, P. Medicinal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): A systematic review. BMC Complementary and Alternative Medicine. 2012; 13: 275. https://doi.org/10.1186/1472-6882-13-275

15. Sharma, R., Martins, N., Kuca, K., Chaudhary, A., Kabra, A., and Rao, M. M. Chyawanprash: A traditional Indian bioactive health supplement. Biomolecules. 2018; 9(5): 161. https://doi.org/10.3390/biom9040161

16. Singh, S., Shankar, R., and Kumar, P. Therapeutic potential of Cinnamomum zeylanicum in metabolic disorders: A review. Journal of Herbal Medicine. 2021; 25: 100404. https://doi.org/10.1016/j.hermed.2021.100404

17. Sunila, E. S., and Kuttan, G. Immunomodulatory and antitumor activity of Piper longum Linn. and piperine. Journal of Ethnopharmacology. 2004; 90(2–3): 339–346. https://doi.org/10.1016/j.jep.2003.09.047

18. World Health Organization. (2021). Noncommunicable diseases: Key facts. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

Received on 25.06.2025 Revised on 14.07.2025

Accepted on 31.07.2025 Published on 12.08.2025

Available online from August 18, 2025

Asian J. Research Chem.2025; 18(4):269-273.

DOI: 10.52711/0974-4150.2025.00042

This work is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License. Creative Commons License.